Business Context and Reporting Period
Gesher Acquisition Corp. II (GSHR) is a Cayman Islands exempted company and a Special Purpose Acquisition Company (SPAC) formed to effect a business combination with one or more target businesses. The company focuses on targets located in Israel, particularly those with international operations in Asia, Europe, or North America, while explicitly excluding entities based in China, Hong Kong, or Macau. The reporting period covers the fiscal year ended December 31, 2025. As of the filing date, the company has not selected a specific target and has generated no operating revenues.
Key Financial Metrics
| Metric | Value (Year Ended Dec 31, 2025) |
|---|---|
| Net Income | $3,473,428 |
| Operating Costs | $1,069,813 |
| Interest Income (Trust Account) | $4,543,241 |
| Trust Account Balance | $148,724,491 |
| Cash Outside Trust Account | $1,093,209 |
| Deferred Underwriting Fee | $5,031,250 |
| Redemption Price (Pro Rata) | ~$10.35 per Public Share |
| Public Shares Outstanding | 14,375,000 |
| Class B Founder Shares | 5,513,483 |
Material Changes and Operational Status
- Initial Public Offering (IPO): Consummated on March 24, 2025, selling 14,375,000 Public Units at $10.00 per unit, generating gross proceeds of $143,750,000. The over-allotment option was fully exercised.
- Private Placement: Simultaneously sold 565,625 Private Placement Units to the Sponsor and BTIG for $5,656,250.
- Trust Account Growth: The Trust Account balance increased from $144,181,250 at IPO to $148,724,491 as of December 31, 2025, driven by interest income on marketable securities.
- Management Change: Sagi Dagan resigned as Chief Financial Officer and Director effective December 31, 2025. Caroline Fu was appointed CFO effective January 1, 2026.
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern due to the mandatory liquidation deadline of December 24, 2026, if a business combination is not consummated.
Guidance, Outlook, and Risks
- Combination Deadline: The company must complete an initial business combination by December 24, 2026 (21 months from IPO). Failure to do so will trigger automatic liquidation and redemption of Public Shares.
- Extension Strategy: The company may seek shareholder approval to extend the Combination Period, which would allow Public Shareholders to redeem their shares.
- Geopolitical Risks: The filing highlights significant risks related to ongoing conflicts in Ukraine and the Middle East (specifically involving the U.S., Israel, and Iran), which could disrupt capital markets and affect the ability to identify or complete a transaction.
- Financing Needs: The company may require additional financing to complete a transaction or fund working capital. The Sponsor has agreed to provide Working Capital Loans up to $1,500,000, which may be convertible into units.
- Redemption Rights: Public shareholders have the right to redeem shares for a pro rata portion of the Trust Account upon the completion of a business combination or liquidation.
Investor Verification Checklist
- Trust Account Liquidity: Verify the current balance and interest rate assumptions for the Trust Account to ensure the redemption price remains stable.
- Extension Provisions: Review the specific terms required to extend the December 24, 2026 deadline and the potential dilution or cash impact of such an extension.
- Target Pipeline: Assess the company's progress in identifying a target, given the focus on the Israeli market and current geopolitical instability.
- Deferred Fees: Confirm the $5,031,250 deferred underwriting fee obligation and its impact on post-transaction cash flow.
- Founder Share Dilution: Understand the anti-dilution provisions for Class B Founder Shares, which may convert at a ratio greater than 1:1 depending on the transaction structure.